Biology of secretory phospholipase A2

106Citations
Citations of this article
72Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The secretory phospholipase A2 (sPLA2) family provides a seemingly endless array of potential biological functions that is only beginning to be appreciated. In humans, this family comprises 9 different members that vary in their tissue distribution, hydrolytic activity, and phospholipid substrate specificity. Through their lipase activity, these enzymes trigger various cell-signaling events to regulate cellular functions, directly kill bacteria, or modulate inflammatory responses. In addition, some sPLA 2's are high affinity ligands for cellular receptors. This review merely scratches the surface of some of the actions of sPLA2s in innate immunity, inflammation, and atherosclerosis. The goal is to provide an overview of recent findings involving sPLA2s and to point to potential pathophysiologic mechanisms that may become targets for therapy. © 2008 Springer Science+Business Media, LLC.

Cite

CITATION STYLE

APA

Boyanovsky, B. B., & Webb, N. R. (2009, February). Biology of secretory phospholipase A2. Cardiovascular Drugs and Therapy. https://doi.org/10.1007/s10557-008-6134-7

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free